Health Professionals | All about ExAller® anti dust mite sprays

Recommended by doctors and allergists.

WATCH THE VIDEO

relies-on-dust-mite-communication-signals

Clinically proven mode of action

Relies on dust mite communication signals

ExAller® contains a dilution of natural plant extracts that mimic the natural pheromones used by dust mites to communicate and cluster together. The solution is sprayed onto a 100%-cotton textile or sheet covering the area to be treated. Within 1-2 hours, more than 80% of the dust mites living in the treated area will be attracted to the covering. The covering can then be washed in hot water (60 degrees Celsius) to eliminate the mites.

This approach allows 99% of dust mites to be removed from mattresses, bedding, carpets and other furniture – eliminating the source of the allergens without killing the mites. ExAller® is insecticide free, 100%-safe and highly effective.

Demonstrated quality and effectiveness

ExAller® is clinically proven to reduce allergy symptoms.

In the clinical study illustrated here, the symptom assessment was based on nasal congestion, rhinorrhea, sneezing, nasal itching and ocular itching. From D0 to D14, participants assessed their symptoms using a 4-point scale: 0=none; 1=mild; 2=moderate; 3=severe. This figure shows symptom scores on D0 (baseline) vs. D14 (1 week after the second treatment).

clinical-study-systematic-quality-controls

graph

In addition to clinical studies, quality assessments are systematically performed by an independent laboratory for each production batch to guarantee consistent effectiveness over time.

These quality assessments follow a strict protocol similar to real-life conditions. They consistently demonstrate the attraction power of the ExAller® solution, as illustrated in this figure.

Download the ExAller® product insert

Download the detailed results

A trusted product developed by a university spin-off

Acar’Up Consumer Health, headquartered in Brussels, launched the ExAller® anti-dust mite solution in 2014 after intensive clinical research by scientists at the Université Libre de Bruxelles the Université Catholique de Louvain.

Originally launched in Belgium under the Acar’Up brand name, the solution has become the first-line therapy prescribed by allergy specialists in Belgium and Europe.

a-trusted-product-developed-by-a-university-spin-off